XBI
Productby State Street Global Advisors
Heard in 40 episodes across 15 shows since Aug 2026
An exchange-traded fund that tracks a broad, relatively equal-weighted basket of U.S. biotechnology companies.
Episodes
This week
Expert statements
Share of the conversation
Mentions of XBI per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 25 | 0.03‰ | 1 |
| Aug 28 | 0.02‰ | 1 |
| Aug 31 | 0.03‰ | 1 |
| Sep 1 | 0.04‰ | 2 |
| Sep 4 | 0.04‰ | 1 |
| Sep 6 | 0.06‰ | 2 |
| Sep 13 | 0.03‰ | 3 |
| Sep 17 | 0.04‰ | 1 |
| Sep 22 | 0.02‰ | 1 |
| Sep 23 | 0.04‰ | 2 |
| Sep 25 | 0.04‰ | 1 |
| Oct 5 | 0.01‰ | 1 |
| Oct 6 | 0.02‰ | 1 |
| Oct 7 | 0.04‰ | 3 |
| Oct 8 | 0.05‰ | 1 |
| Oct 9 | 0.06‰ | 1 |
| Oct 13 | 0.05‰ | 1 |
| Oct 14 | 0.03‰ | 1 |
| Oct 16 | 0.05‰ | 4 |
| Oct 20 | 0.06‰ | 2 |
| Oct 23 | 0.04‰ | 3 |
| Oct 26 | 0.05‰ | 1 |
| Oct 27 | 0.04‰ | 1 |
| Oct 30 | 0.03‰ | 2 |
| Oct 31 | 0.04‰ | 1 |
| Nov 6 | 0.02‰ | 2 |
| Nov 12 | 0.02‰ | 1 |
| Nov 13 | 0.02‰ | 1 |
| Nov 20 | 0.01‰ | 1 |
Email alert
Email me when XBI comes up on a podcast
One email a week at most, with the new episodes that mention XBI. Free, no account needed, unsubscribe in one click.
What experts have said about XBI
6 statements · 3 positive · 3 negative
The XBI’s rise indicates an exceptionally strong biotech market year.
“the XBI started the year at 108, it's at 150. By any measure, this is one of the best biotech markets of all time”
Open the episode · Episode 200 - October 23, 2026Listen at 45:01
The XBI is currently under pressure.
“The XBI is under pressure again today.”
Open the episode · Episode 199 - October 16, 2026Listen at 0:44
The XBI is up 20% year to date.
“The XBI ETF is still up a very healthy 20% for the year.”
Open the episode · Episode 199 - October 16, 2026Listen at 1:02
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
40 episodes featuring XBI, newest first
- Nov 20, 2026
Nvidia sell-off exposes wider cracks in the AI tradeCNBC's "Fast Money"Nov 20, 2026 - Nov 15, 2026
Biotech investors weigh gene editing, MASH data and RAS riskBreaking BiotechNov 15, 2026 - Nov 13, 2026
Biotech launches expose the gap between forecasts and adoptionBiotech HangoutNov 13, 2026 - Nov 12, 2026
Higher yields test a tentative stock-market rallyStock Market Today With IBDNov 12, 2026 - Nov 9, 2026
Biotech investors weigh obesity, RAS drugs and Moderna catalystsBreaking BiotechNov 9, 2026 - Nov 6, 2026
Election stakes meet biotech’s regulatory and pipeline risksBiotech HangoutNov 6, 2026